Press Releases

Disease awareness campaign encourages men to overcome their embarrassment and openly discuss Peyronie's disease (PD), taking charge of their health. Campaign empowers men to connect with trusted...

MALVERN, PA, December 20, 2024 – Endo, Inc (OTCQX: NDOI) (“Endo”), announced today that one of its operating subsidiaries, Endo USA, Inc., is voluntarily recalling all lots within expiry of...

Endo, Inc. (OTCQX: NDOI) announced today the publication of the Peyronie's disease (PD) self-assessment screening app by the peer-reviewed journal Translational Andrology and Urology. Read the...

Endo, Inc. (OTCQX: NDOI) announced today that it has begun shipping doxycycline for injection, USP 100 mg/vial, an AP-rated version of DOXY 100™. "We're pleased to provide choices to healthcare...

20,000-square-foot site increases Endo's sterile injectable production capacity This marks the site's first U.S. FDA approval Endo is investing and innovating in its Injectable Solutions business...